Summit Therapeutics plc (SMMT): Price and Financial Metrics
SMMT Price/Volume Stats
| Current price | $18.62 | 52-week high | $33.89 |
| Prev. close | $20.00 | 52-week low | $1.89 |
| Day low | $18.31 | Volume | 1,781,900 |
| Day high | $19.97 | Avg. volume | 3,557,704 |
| 50-day MA | $21.33 | Dividend yield | N/A |
| 200-day MA | $10.68 | Market Cap | 13.73B |
SMMT Stock Price Chart Interactive Chart >
Summit Therapeutics plc (SMMT) Company Bio
Summit Therapeutics plc operates as a biopharmaceutical company primarily in the United Kingdom and the Unites States. It focuses on the discovery, development, and commercialization of novel medicines to treat the Duchenne Muscular Dystrophy (DMD), a fatal muscle wasting disease; and infections caused by Clostridium difficile bacteria (CDI). The company was founded in 2003 and is based in Abingdon, England.
SMMT Price Returns
| 1-mo | -9.57% |
| 3-mo | 42.35% |
| 6-mo | 450.89% |
| 1-year | 854.87% |
| 3-year | 259.46% |
| 5-year | 1,133.11% |
| YTD | 613.41% |
| 2023 | -38.59% |
| 2022 | 57.99% |
| 2021 | -42.77% |
| 2020 | 193.75% |
| 2019 | 39.13% |
Continue Researching SMMT
Here are a few links from around the web to help you further your research on Summit Therapeutics plc's stock as an investment opportunity:Summit Therapeutics plc (SMMT) Stock Price | Nasdaq
Summit Therapeutics plc (SMMT) Stock Quote, History and News - Yahoo Finance
Summit Therapeutics plc (SMMT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...